Inspire Change In Cash vs Sale Purchase Of Stock Analysis

INSP Stock

USD 192.76 1.24 0.64%

Inspire Medical financial indicator trend analysis is infinitely more than just investigating Inspire Medical Systems recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Inspire Medical Systems is a good investment. Please check the relationship between Inspire Medical Change In Cash and its Sale Purchase Of Stock accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inspire Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Change In Cash vs Sale Purchase Of Stock

Change In Cash vs Sale Purchase Of Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Inspire Medical Systems Change In Cash account and Sale Purchase Of Stock. At this time, the significance of the direction appears to have weak relationship.

The correlation between Inspire Medical's Change In Cash and Sale Purchase Of Stock is 0.3. Overlapping area represents the amount of variation of Change In Cash that can explain the historical movement of Sale Purchase Of Stock in the same time period over historical financial statements of Inspire Medical Systems, assuming nothing else is changed. The correlation between historical values of Inspire Medical's Change In Cash and Sale Purchase Of Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Change In Cash of Inspire Medical Systems are associated (or correlated) with its Sale Purchase Of Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Sale Purchase Of Stock has no effect on the direction of Change In Cash i.e., Inspire Medical's Change In Cash and Sale Purchase Of Stock go up and down completely randomly.

Correlation Coefficient

0.3

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Change In Cash

Sale Purchase Of Stock

Most indicators from Inspire Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Inspire Medical Systems current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inspire Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

At this time, Inspire Medical's Selling General Administrative is relatively stable compared to the past year. As of 11/29/2024, Tax Provision is likely to grow to about 939.8 K, though Enterprise Value Over EBITDA is likely to grow to (322.99).

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	2.0M	2.9M	2.8M	1.7M
Interest Income	125K	5.1M	18.1M	19.0M

Depreciation And Amortization Interest Income

Inspire Medical fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab
Common Stock Shares Outstanding		0.84	0.56	0.84	0.8	0.84	0.65	0.87	0.68	-0.8	-0.91	0.73	0.82	0.7	0.39	0.56	0.91	0.78	0.92	0.56	0.6	0.88	0.7	0.84	0.94	0.92
Total Assets	0.84		0.37	0.99	0.98	1.0	0.67	0.99	0.93	-0.8	-0.98	0.97	0.79	0.94	0.74	0.51	0.91	0.98	0.82	0.51	0.46	1.0	0.9	0.98	0.91	0.9
Short Long Term Debt Total	0.56	0.37		0.33	0.3	0.35	0.17	0.42	0.33	-0.13	-0.45	0.24	0.18	0.34	0.25	0.67	0.34	0.31	0.62	0.67	0.94	0.43	0.44	0.49	0.41	0.49
Other Current Liab	0.84	0.99	0.33		0.99	0.99	0.7	0.98	0.94	-0.79	-0.98	0.98	0.77	0.95	0.75	0.43	0.89	0.99	0.79	0.43	0.41	0.98	0.93	0.98	0.9	0.9
Total Current Liabilities	0.8	0.98	0.3	0.99		0.97	0.71	0.95	0.96	-0.76	-0.96	0.99	0.74	0.97	0.79	0.34	0.85	0.99	0.73	0.34	0.36	0.96	0.95	0.98	0.86	0.88
Total Stockholder Equity	0.84	1.0	0.35	0.99	0.97		0.66	0.99	0.92	-0.81	-0.97	0.97	0.79	0.93	0.73	0.51	0.92	0.98	0.82	0.51	0.45	0.99	0.89	0.97	0.92	0.9
Other Liab	0.65	0.67	0.17	0.7	0.71	0.66		0.62	0.65	-0.65	-0.72	0.7	0.65	0.65	0.46	0.12	0.67	0.7	0.64	0.12	0.22	0.65	0.66	0.68	0.73	0.74
Net Tangible Assets	0.87	0.99	0.42	0.98	0.95	0.99	0.62		0.89	-0.82	-0.97	0.93	0.81	0.9	0.68	0.57	0.93	0.95	0.87	0.57	0.51	1.0	0.87	0.96	0.93	0.91
Property Plant And Equipment Net	0.68	0.93	0.33	0.94	0.96	0.92	0.65	0.89		-0.57	-0.89	0.98	0.54	1.0	0.93	0.33	0.74	0.98	0.63	0.33	0.41	0.9	0.99	0.96	0.75	0.81
Net Debt	-0.8	-0.8	-0.13	-0.79	-0.76	-0.81	-0.65	-0.82	-0.57		0.83	-0.71	-1.0	-0.58	-0.24	-0.31	-0.88	-0.73	-0.75	-0.31	-0.17	-0.82	-0.54	-0.71	-0.86	-0.75
Retained Earnings	-0.91	-0.98	-0.45	-0.98	-0.96	-0.97	-0.72	-0.97	-0.89	0.83		-0.93	-0.83	-0.9	-0.65	-0.48	-0.91	-0.96	-0.86	-0.48	-0.5	-0.99	-0.89	-0.97	-0.93	-0.92
Accounts Payable	0.73	0.97	0.24	0.98	0.99	0.97	0.7	0.93	0.98	-0.71	-0.93		0.68	0.98	0.85	0.34	0.82	1.0	0.69	0.34	0.33	0.94	0.95	0.96	0.83	0.84
Cash	0.82	0.79	0.18	0.77	0.74	0.79	0.65	0.81	0.54	-1.0	-0.83	0.68		0.56	0.2	0.33	0.89	0.71	0.77	0.33	0.21	0.81	0.52	0.7	0.87	0.77
Non Current Assets Total	0.7	0.94	0.34	0.95	0.97	0.93	0.65	0.9	1.0	-0.58	-0.9	0.98	0.56		0.91	0.33	0.75	0.98	0.65	0.33	0.41	0.91	0.99	0.96	0.77	0.83
Non Currrent Assets Other	0.39	0.74	0.25	0.75	0.79	0.73	0.46	0.68	0.93	-0.24	-0.65	0.85	0.2	0.91		0.24	0.48	0.83	0.38	0.24	0.36	0.69	0.9	0.8	0.5	0.6
Long Term Debt	0.56	0.51	0.67	0.43	0.34	0.51	0.12	0.57	0.33	-0.31	-0.48	0.34	0.33	0.33	0.24		0.52	0.37	0.76	1.0	0.83	0.55	0.33	0.49	0.53	0.45
Cash And Short Term Investments	0.91	0.91	0.34	0.89	0.85	0.92	0.67	0.93	0.74	-0.88	-0.91	0.82	0.89	0.75	0.48	0.52		0.84	0.91	0.52	0.46	0.93	0.71	0.85	0.99	0.95
Net Receivables	0.78	0.98	0.31	0.99	0.99	0.98	0.7	0.95	0.98	-0.73	-0.96	1.0	0.71	0.98	0.83	0.37	0.84		0.73	0.37	0.39	0.96	0.96	0.98	0.85	0.87
Common Stock Total Equity	0.92	0.82	0.62	0.79	0.73	0.82	0.64	0.87	0.63	-0.75	-0.86	0.69	0.77	0.65	0.38	0.76	0.91	0.73		0.76	0.72	0.86	0.64	0.8	0.93	0.89
Long Term Debt Total	0.56	0.51	0.67	0.43	0.34	0.51	0.12	0.57	0.33	-0.31	-0.48	0.34	0.33	0.33	0.24	1.0	0.52	0.37	0.76		0.83	0.55	0.33	0.49	0.53	0.45
Non Current Liabilities Total	0.6	0.46	0.94	0.41	0.36	0.45	0.22	0.51	0.41	-0.17	-0.5	0.33	0.21	0.41	0.36	0.83	0.46	0.39	0.72	0.83		0.51	0.47	0.55	0.51	0.56
Capital Surpluse	0.88	1.0	0.43	0.98	0.96	0.99	0.65	1.0	0.9	-0.82	-0.99	0.94	0.81	0.91	0.69	0.55	0.93	0.96	0.86	0.55	0.51		0.88	0.98	0.93	0.91
Inventory	0.7	0.9	0.44	0.93	0.95	0.89	0.66	0.87	0.99	-0.54	-0.89	0.95	0.52	0.99	0.9	0.33	0.71	0.96	0.64	0.33	0.47	0.88		0.96	0.74	0.82
Other Current Assets	0.84	0.98	0.49	0.98	0.98	0.97	0.68	0.96	0.96	-0.71	-0.97	0.96	0.7	0.96	0.8	0.49	0.85	0.98	0.8	0.49	0.55	0.98	0.96		0.88	0.9
Other Stockholder Equity	0.94	0.91	0.41	0.9	0.86	0.92	0.73	0.93	0.75	-0.86	-0.93	0.83	0.87	0.77	0.5	0.53	0.99	0.85	0.93	0.53	0.51	0.93	0.74	0.88		0.97
Total Liab	0.92	0.9	0.49	0.9	0.88	0.9	0.74	0.91	0.81	-0.75	-0.92	0.84	0.77	0.83	0.6	0.45	0.95	0.87	0.89	0.45	0.56	0.91	0.82	0.9	0.97

Click cells to compare fundamentals

Inspire Medical Account Relationship Matchups

Inspire Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	23.8M	26.1M	27.3M	28.1M	29.3M	22.9M
Total Assets	181.3M	281.2M	295.1M	564.9M	676.8M	710.7M
Short Long Term Debt Total	25.4M	30.6M	33.8M	8.9M	24.8M	24.8M
Other Current Liab	12.4M	13.5M	20.1M	33.0M	39.3M	41.2M
Total Current Liabilities	16.9M	20.7M	41.3M	61.2M	78.1M	82.0M
Total Stockholder Equity	139.8M	229.7M	229.0M	496.0M	572.5M	601.1M
Net Tangible Assets	139.8M	229.7M	229.0M	496.0M	570.4M	598.9M
Property Plant And Equipment Net	4.0M	11.1M	16.4M	24.1M	62.7M	65.8M
Net Debt	1.7M	(159.9M)	(180.7M)	(432.7M)	(160.7M)	(168.7M)
Retained Earnings	(180.2M)	(237.3M)	(279.4M)	(324.3M)	(345.4M)	(362.7M)
Accounts Payable	4.5M	7.2M	11.7M	26.8M	38.8M	40.8M
Cash	22.9M	190.5M	214.5M	441.6M	185.5M	160.6M
Non Current Assets Total	10.6M	11.3M	26.5M	34.8M	83.1M	87.2M
Non Currrent Assets Other	802K	381K	204K	215K	11.3M	11.8M
Long Term Debt	24.9M	24.5M	24.7M	15.8M	18.2M	21.8M
Cash And Short Term Investments	149.5M	234.4M	214.5M	451.4M	460.4M	236.7M
Net Receivables	13.1M	25.1M	34.2M	61.2M	89.9M	94.4M
Common Stock Total Equity	23K	24K	27K	29K	33.4K	22.6K
Short Term Investments	90.9M	126.6M	43.8M	9.8M	274.8M	288.6M
Long Term Debt Total	24.9M	24.5M	24.7M	15.8M	18.2M	21.8M
Liabilities And Stockholders Equity	181.3M	281.2M	295.1M	564.9M	676.8M	710.7M
Non Current Liabilities Total	24.6M	30.7M	24.7M	7.7M	26.2M	23.1M
Capital Surpluse	319.9M	467.0M	508.5M	820.3M	943.4M	990.6M
Inventory	5.8M	8.5M	17.2M	11.9M	33.9M	35.6M
Other Current Assets	2.2M	3.9M	5.3M	5.5M	9.6M	10.1M
Other Stockholder Equity	319.9M	467.0M	508.5M	820.3M	917.1M	478.1M
Total Liab	41.4M	51.4M	66.0M	68.9M	104.3M	56.6M
Property Plant And Equipment Gross	4.0M	11.1M	16.4M	24.1M	69.9M	73.4M
Total Current Assets	170.6M	269.9M	268.5M	530.0M	593.7M	623.4M
Accumulated Other Comprehensive Income	102K	29K	(55K)	(86K)	800K	840K
Common Stock	23K	24K	27K	29K	30K	23.9K
Property Plant Equipment	4.0M	5.3M	16.4M	17.2M	19.8M	20.8M
Net Invested Capital	164.4M	254.5M	254.0M	496.0M	572.5M	306.2M
Net Working Capital	153.8M	249.1M	227.2M	468.8M	515.6M	286.0M
Retained Earnings Total Equity	(180.2M)	(237.3M)	(279.4M)	(324.3M)	(291.8M)	(306.4M)

Pair Trading with Inspire Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inspire Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inspire Medical will appreciate offsetting losses from the drop in the long position's value.

Moving against Inspire Stock

0.62	DXCM	DexCom Inc Sell-off Trend	Pair Corr
0.59	LH	Laboratory	Pair Corr
0.54	VREX	Varex Imaging Corp	Pair Corr
0.48	GH	Guardant Health	Pair Corr
0.44	ENOV	Enovis Corp	Pair Corr

The ability to find closely correlated positions to Inspire Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inspire Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inspire Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inspire Medical Systems to buy it.

The correlation of Inspire Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inspire Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inspire Medical Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Inspire Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Inspire Stock Analysis

When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC